Opendata, web and dolomites

MOsteoDD

PLATFORM FOR THE FRONTLINE OF OSTEOPOROSIS PREVENTION

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MOsteoDD project word cloud

Explore the words cloud of the MOsteoDD project. It provides you a very rough idea of what is the project "MOsteoDD" about.

service    venture    doctor    serve    health    pace    company    maturing    fast    chemical    globally    95    stage    customer    market    validation    population    prevention    medical    burden    trl    mark    seconds    time    bones    prevent    fractures    flags    bio    diagnostic    care    spectroscopy    small    opportunity    accuracy    diagnosed    electrode    innovative    osteoporosis    data    clinical    provides    smei    issued    onset    citizens    broken    reducing    directed    vitae    device    diagnosis    aging    dexa    worth    impedance    ce    union    screening    first    invasive    diagnostics    mvp    output    bonevitae    prescriptions    efficient    9bn    efforts    enne    tools    core       enter    ict    eacute    written    detection    mosteodd    2050    elderly    billion    doctors    attributed    scanning    annual    web    76    europ    report    mission    powerful    patients    osteoscanner    poland    patented    seeking    platform    women    start    composition    36bn    six    wroclaw    generate    bone    frontline    direct    painless    pl    version    conformit    minimum    readiness    setup   

Project "MOsteoDD" data sheet

The following table provides information about the project.

Coordinator
BONE VITAE SPOLKA AKCYJNA 

Organization address
address: MUCHOBORSKA, NR 18
city: WROCLAW
postcode: 54 424
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Poland [PL]
 Project website http://www.bonevitae.pl/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-07-01   to  2016-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BONE VITAE SPOLKA AKCYJNA PL (WROCLAW) coordinator 50˙000.00

Map

 Project objective

Osteoporosis is the most common reason for broken bones among elderly women. In the European Union, annual direct medical costs of fractures attributed to osteoporosis reach €36bn and are expected to rise to €76.9bn by 2050 in pace with the aging of population. Early diagnosis and prevention is the key to reducing this burden and deliver more efficient health care to European citizens with new tools for doctors to better serve their patients. Our mission at BONE VITAE (www.bonevitae.pl, Wroclaw, Poland) is to implement fast in-practice medical screening for early flags of osteoporosis with our patented osteoscanner ICT platform, the new frontline of prevention. Our non-invasive and painless bio-impedance spectroscopy technology is the only one that provides data on bone composition and chemical changes that mark the very start of osteoporosis onset, when there is still time to prevent it. The Multi-electrode Osteoporosis Detection Device (MOsteoDD) platform is an exciting market opportunity for our company, a small, highly innovative venture with a powerful patented core technology seeking to enter the growth market of osteoporosis diagnostics worth $6–7 billion a year globally. Our patented six-electrode setup provides 95% diagnostic accuracy results in less than 40 seconds, while the platform’s web service will analyse the device output and generate a written report for doctor’s use allowing pre-diagnosed patients to be referred for further scanning (DEXA) or for prescriptions to be issued. The first version of the MOsteoDD osteoscanner has clinical validation in Poland and the CE mark (Conformité Européenne), and is currently at Minimum Viable Product (MVP) stage at Technology Readiness Level (TRL) 8. Current efforts are directed at maturing the platform to specific customer needs to reach the market with the support of SMEI funding.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MOSTEODD" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MOSTEODD" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

PRIDIKTIV (2017)

Pridiktiv - Exploring European expansion through 4 pilot studies

Read More  

ClearRing (2018)

An innovative, minimally invasive medical device used for treatment of Benign Prostatic Hyperplasia symptoms.

Read More